Keros Therapeutics Inc (KROS) financials · rev $243.9M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Keros Therapeutics Inc (KROS) rev $243.9M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $243.9M | N/A |
| Operating Income | $67.6M | -$210.8M |
| Net Income | $87.0M | -$187.4M |
| EPS (Diluted) | $2.30 | -$5.00 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $338.0M | $615.9M |
| Current Assets | $315.4M | $588.9M |
| Cash & Equivalents | $287.4M | $559.9M |
| PP&E | $4.30M | $4.24M |
| Total Liabilities | $34.9M | $44.3M |
| Current Liabilities | $20.4M | $27.4M |
| Shareholders' Equity | $303.1M | $571.6M |
| Retained Earnings | -$481.8M | -$568.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $107.5M | -$160.9M |
| CapEx | $1.55M | $1.93M |
| Investing Cash Flow | -$1.55M | -$1.93M |
| Financing Cash Flow | -$378.5M | $391.8M |
| Net Change in Cash | -$272.5M | $229.0M |
| Free Cash Flow | $106.0M | -$162.8M |
FAQ
What is KROS P/E and revenue?
Keros Therapeutics Inc (KROS) rev $243.9M.
What is KROS revenue?
Keros Therapeutics Inc last cached revenue is $243.9M (FY2025).
Is KROS profitable?
Keros Therapeutics Inc last cached net income is $87.0M (FY2025).
What are KROS total assets?
Keros Therapeutics Inc last cached total assets are $338.0M (FY2025).
What is KROS free cash flow?
Keros Therapeutics Inc last cached free cash flow is $106.0M (FY2025).
Not investment advice. Cached statements, not a live tape.